CompletedPhase 1ACTRN12605000528651
A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism
Sponsor
Acrux DDS Pty Ltd
Enrollment
12 participants
Start Date
Apr 5, 2005
Study Type
Interventional
Conditions
Eligibility
Sex: Females
Plain Language Summary
Simplified for easier understanding
This is a clinical study looking at: A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism. It may be open to women. Key requirements include: Healthy volunteers Participation typically involves medical assessments and follow-up visits as part of the research.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Testosterone Metered Dose (MD) Lotion, single dose.
Testosterone Metered Dose (MD) Lotion, single dose.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000528651
Related Trials
Inherited Reproductive Disorders
NCT015004472 locations
Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality
NCT075464351 location
Observation of Environment and Reproductive-Endocrine Effects
NCT062808071 location
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
NCT062472671 location
IMmune checkPoint inhibitor related gonAdal toxiCiTy in premenopausal women and men with melanoma – the IMPACT study
ACTRN126250003954376 locations